Leuplinection Side Effects
View Community-reported Leuplinection side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Leuplinection Side Effect
Have You dealt with a Leuplinection side effect? Share your experience
Leuplinection Side Effects submitted to FDA
Total Leuplinection reports: 6.Leuplinection FDA safety alerts: No.
Reported deaths: 2 Reported hospitalizations: 4.
Take Leuplinection Side Effects Survey, Discuss Leuplinection with others
FDA Reported Leuplinection Side Effects: pulmonary mycosis, pulmonary alveolar haemorrhage, polymyositis, interstitial lung disease, condition aggravated, blood creatine phosphokinase increased, antinuclear antibody positive, uterine cancer, pneumonia, myelodysplastic syndrome, malaise,
More About Leuplinection.
If you have questions about Leuplinection, you can ask a Health Expert or Ask Patient Community about Leuplinection.
Leuplinection Side Effects Report #5391804-X
Physician from JAPAN reported LEUPLINECTION problem on July 12, 2007. Male patient, 68 years of age, was diagnosed with prostate cancer and was treated with LEUPLINECTION. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, blood creatine phosphokinase increased, condition aggravated, interstitial lung disease, polymyositis, pulmonary alveolar haemorrhage, pulmonary mycosis. LEUPLINECTION dosage: 3.75 MG (3.75 MG, 1 IN 28 D); SUBCUTANEOUS. During the same period patient was treated with CASODEX, TAMSULOSIN, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient died.
Leuplinection Side Effects Report #5391804-X
LEUPLINECTION problem was reported by a Physician from JAPAN on July 12, 2007. Male patient, 68 years of age, was diagnosed with prostate cancer and was treated with LEUPLINECTION. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, blood creatine phosphokinase increased, condition aggravated, interstitial lung disease, polymyositis, pulmonary alveolar haemorrhage, pulmonary mycosis. LEUPLINECTION dosage: 3.75 MG (3.75 MG, 1 IN 28 D); SUBCUTANEOUS. During the same period patient was treated with CASODEX, TAMSULOSIN, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient died.
Leuplinection Side Effects Report #5768161-X
Physician from JAPAN reported LEUPLINECTION problem on June 03, 2008. Female patient, 33 years of age, was diagnosed with uterine leiomyoma and was treated with LEUPLINECTION. After drug was administered, patient experienced the following problems/side effects: haemorrhagic cerebral infarction. LEUPLINECTION dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
Leuplinection Side Effects Report #5776879-8
LEUPLINECTION problem was reported by a Physician from JAPAN on June 09, 2008. Female patient, 49 years of age, was diagnosed with uterine leiomyoma and was treated with LEUPLINECTION. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspnoea, hepatic function abnormal, hyperthyroidism. LEUPLINECTION dosage: unknown. Patient recovered.
Leuplinection Side Effects Report #5793058-9
Physician from JAPAN reported LEUPLINECTION problem on June 03, 2008. Female patient, 33 years of age, was diagnosed with uterine leiomyoma and was treated with LEUPLINECTION. After drug was administered, patient experienced the following problems/side effects: haemorrhagic cerebral infarction. LEUPLINECTION dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
Leuplinection Side Effects Report #5259328-8
LEUPLINECTION problem was reported by a Consumer or non-health professional from JAPAN on Feb 26, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer and was treated with LEUPLINECTION. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. LEUPLINECTION dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE, MAGLAX, LIPOVAS, FLIVAS. Patient recovered.